| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-04-01 14:58 Tx date 2026-03-31 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
56 - Grant of rights
|
+501,000 vol |
876,000 | |
| Filed 2026-04-01 14:57 Tx date 2026-03-31 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$89,700
+195,000 vol $0.46 each |
570,000 | |
| Filed 2026-03-31 14:05 Tx date 2026-03-30 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,440
+14,000 vol $0.46 each |
189,000 | |
| Older filings | ||||||
| Filed 2026-03-23 15:36 Tx date 2026-03-20 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-174,000
-20,000 vol $8.70 each |
0 | |
| Filed 2026-03-23 15:36 Tx date 2026-03-19 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+20,000 vol |
20,000 | |
| Filed 2026-03-23 15:35 Tx date 2026-03-19 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-20,000 vol |
36,300 | |
| Filed 2026-03-23 15:35 Tx date 2026-03-18 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,296.96
-2,486 vol $7.36 each |
0 | |
| Filed 2026-03-23 15:33 Tx date 2025-05-01 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
56,300 | ||
| Filed 2026-03-23 15:33 Tx date 2025-05-01 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
10,715 | ||
| Filed 2026-03-23 15:33 Tx date 2025-05-01 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,486 | ||
| Filed 2025-12-18 11:41 Tx date 2025-11-30 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-140,000
-140,000 vol $1.00 each |
375,000 | |
| Filed 2025-11-27 14:45 Tx date 2025-11-27 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$54,750
+150,000 vol $0.365 each |
175,000 | |
| Filed 2025-11-27 14:44 Tx date 2025-11-26 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+15,000 vol $0.35 each |
25,000 | |
| Filed 2025-11-04 23:06 Tx date 2025-05-21 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+375,000 vol |
515,000 | |
| Filed 2025-11-04 23:01 Tx date 2025-05-21 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
140,000 | ||
| Filed 2025-11-04 23:01 Tx date 2025-05-21 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
00 - Opening Balance-Initial SEDI Report
|
375,000 | ||
| Filed 2025-11-04 15:35 Tx date 2025-08-19 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,800
+10,000 vol $0.28 each |
10,000 | |
| Filed 2025-11-04 14:48 Tx date 2025-05-21 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-04 14:47 Tx date 2025-05-21 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
30 - Acquisition or disposition under a purchase/ownership plan
|
+93,750 vol |
||
| Filed 2025-11-04 14:47 Tx date 2025-05-21 |
$NPTH
NeuPath Health Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
30 - Acquisition or disposition under a purchase/ownership plan
|
+93,750 vol |
||